Navigation Links
AMRI Promotes Daniel Conlon to Senior Director of Business Development
Date:9/10/2012

ALBANY, N.Y., Sept. 10, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that Daniel Conlon has been promoted to Senior Director, Business Development, AMRI, reporting to Christopher Conway, Vice President, Business Development, North America.

(Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO )

In this newly created role, Conlon will lead AMRI's development and manufacturing services sales team for North America. His responsibilities will include assisting with the strategic direction for generating sales in the North American territory and with the execution of revenue goals for his team.

"Dan is a leader in the truest sense of the word," Mr. Conway says. "He has the proven ability to energize a team while setting the highest attainable standards. Dan's sales and management experience makes him ideal for this position."

Conlon's demonstrated knowledge and ability to sell AMRI's development and manufacturing services earned him the top sales position in 2012. Before joining AMRI in 2010, Conlon held a sales and management position with Merck, formally Organon BioSciences. He worked for Merck/Organon for eight years starting as a Sales Representative/District Trainer. Following this role, he was promoted to District Sales Manager overseeing a team across multistate districts.

"The strengthening of our Business Development team will help us build upon an already solid foundation for growth and will further enhance AMRI's strategic SMARTSOURCING™ approach," said Thomas D'Ambra, Ph.D., AMRI's Chairman, President and Chief Executive Officer. "We are very encouraged by the talented and motivated people on our team, and the prospects for continued growth in the future."

About AMRI
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For press releases and additional information about the company, please visit www.amriglobal.com.

 

 

 


'/>"/>
SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nile Therapeutics Promotes Darlene Horton, M.D., to Chief Executive Officer and Director
2. Diplomat Specialty Pharmacy Promotes Dr. Atheer Kaddis to Sr. Vice President of Sales and Marketing
3. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
4. Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
5. Conatus Pharmaceuticals Appoints Daniel Ripley As Head Of Corporate Development
6. Study Confirms Daniels Sharpsmart Helps Hospitals Reduce Carbon Footprint
7. Daniel Sontupe, SVP, Director of Market Access, at The CementBloc, to Present on Uncovering the Value in a Patient Support Program at CBI Summit
8. Okuma America Chooses The Daniel Group To Provide Customer Service Research
9. Catalent Pharma Solutions, Inc. Announces Increase In Tender Cap For Its Cash Tender Offer For Its 9-1/2%/10-1/4% Senior PIK-Election Notes Due 2015
10. Catalent Pharma Solutions, Inc. Announces Cash Tender Offer for up to $250 Million of Its 9-1/2%/10-1/4% Senior PIK-Election Notes due 2015
11. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Research and Markets has announced the addition of ... offering. ... report forecasts the global optical transceiver market to grow at a ... report covers the present scenario and the growth prospects of the ... the report considers the revenue generated from the shipment of optical ...
(Date:12/9/2016)...  Harmar Mobility, LLC announced today that Steven E. Dawson has been ... of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... Harmar ... Mr. Dawson,s executive career includes leadership roles managing ... of industries. He brings to the company deep operational and leadership expertise, ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a ... to address severe, rare diseases, today announced that senior management will ... Success Healthcare Conference at the InterContinental Barclay Hotel in ... 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma is engaged ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... The ... Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits and ... the District of Columbia as an education tool in the war against teen drug ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution of the latest ... readers to sign up as an organ donor for the 123,000 people in the ... organ donor can save up to 8 saves through organ donation and enhance many ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... "I had ... an inventor from Winchester, Va. "I thought that if the nebulizer had a more ... rather than fearing them." , He developed the patent-pending NEBY to avoid the need ...
(Date:12/8/2016)... ... 08, 2016 , ... The Florida Hospital Tampa Wound Healing ... Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute ... and facilities have earned this distinction. This is the second time the Florida ...
(Date:12/8/2016)... ... 2016 , ... ZyDoc , a New York-based medical ... Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” has ... usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ natural ...
Breaking Medicine News(10 mins):